Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Don’t Just Archive: Enterprise

Health Information System (HIS)

Moving to a new Health Information System (HIS) may be a necessity, but it doesn’t have to be a headache. Whether the result of mergers or acquisitions, the need to consolidate disparate systems, or the desire to upgrade, many hospitals and health systems are transitioning to a new HIS. But while about three years’ worth of data will convert to the new system, what happens to the rest of the patient data, revenue cycle data, CT scans, labs, etc.? That’s where an active enterprise data archive comes in.

Don’t Let Go, Get Better

It can be scary to transition to new health information technology, knowing clinicians and staff still need access to the data that used to live in the EMR (Electronic Medical Record), ERP (Enterprise Resource Planning) or Patient Accounting applications that have just been replaced. Letting go can be complicated, but there is a way to access all the data that didn’t make it into the new system and save time and money in the process.

Too often, organizations have several legacy systems up and running, incurring high vendor fees and dedicated staff time to manage what is essentially an electronic file cabinet. In fact, some reports show that as much as 60 to 80 percent of hospital IT budgets are spent maintaining legacy applications and their mainframe components.

An alternative is to shut down those legacy systems, and any soon to be retired systems, and move to an archive solution. There are choices here, too.

Offline Archives vs. Active Enterprise Data Archives

The type of information, how often clinicians and staff access it and what they do with it will determine whether an organization should opt for an offline archive, an active enterprise archive or a combination of both.

Offline archives work best when users don’t: frequently access the information; need a graphical user interface; or need to use the data in reporting or workflows, for example, records that are 10 or more years old, or PDFs. However, an active enterprise data archive is the way to go if: billing staff needs to continue working down accounts receivable (AR); Health Information Management needs to fulfill information requests; Human Resources needs to respond to audits; Legal needs documentation; or clinicians need to access patient histories.

An active enterprise archiving platform centralizes data storage and integrates with the new HIS. It allows for real-time, in-context access to the data and makes it accessible for reporting and workflow functionality, including AR work downs. It also provides a longitudinal view of patient records.

Moreover, an active archive can save millions of dollars and avoid data loss that can lead to noncompliance with federal guidelines and issues with cash flow. For example, Yale New Haven Health saved $2.6 million annually in legacy costs when it went from five EHRs (Electronic Health Records) to one – and integrated that system with a revenue cycle and active legacy data platform.

For Best Results, Decide Early

Deciding what to do with legacy data early in the process of choosing a new HIS will help set organizations up for more successful transitions. An enterprise archiving strategy ensures continued and easy access to the legacy information clinicians and staff need, when and how they need it. And in turn, it encourages user adoption and maximizes the return on investment of the new applications.

Philips introduces OmniWire, the world’s first solid core pressure guide wire for coronary artery interventional procedures

Philips introduces OmniWire, the world's first solid core pressure guide wire for coronary artery interventional procedures

Royal Philips, a global leader in health technology, announced the introduction of OmniWire, the world’s first solid core pressure wire for coronary artery interventional procedures. With its breakthrough solid core construction, physicians can more easily maneuver the wire in the patient’s circulatory system to measure blood pressure along the vessel and guide the delivery of catheters and stents.

The new wire supports iFR (instant wave-Free Ratio) measurements, the only resting index supported by randomized controlled outcome trials [1-3], as well as FFR (fractional flow reserve) measurements. It also integrates with the Philips IntraSight interventional applications platform, which can co-register iFR data onto the angiogram (interventional X-ray image) to precisely identify the parts of vessels requiring treatment.

Traditional pressure wires use a hollow metal tube (hypotube) to house the wiring that transmits the pressure information. Due to their thin walls, these wires can be challenging to maneuver and can sometimes kink, potentially becoming damaged during the procedure. OmniWire is the world’s first solid core pressure guidewire, using advanced conductive ribbons embedded in its outer polymer layer to communicate pressure information. The front (distal) part of the wire is made from Nitinol, a super-elastic, durable material that is commonly used in non-diagnostic, interventional ‘workhorse’ guide wires. The back (proximal) part of the wire is constructed from a high-strength cobalt alloy that provides the high durability required for complex and multi-vessel cases.

“I have been very impressed with the handling of OmniWire, the new solid core design performed beautifully, and I was able to navigate the difficult case easily,” said Dr. Jasvindar Singh, director of the catheterization lab at Barnes Jewish Hospital and associate professor at Washington University in St. Louis, U.S., who performed the first human case with OmniWire in the country. “We used iFR co-registration and found that the patient needed a stent. I was then able to perform the whole procedure working over OmniWire. This is truly an innovation in percutaneous coronary interventions.”

The new wire supports both iFR and FFR indices. iFR continues to be adopted into clinical practice and has been validated in clinical outcomes studies with data from over 4,500 patients [1,2] as well as being recognized by the European Society of Cardiology (ESC), the Society for Cardiovascular Angiography and Interventions (SCAI) and the American College of Cardiology (ACC) [4-6].

OmniWire integrates with IntraSight, Philips’ secure interventional applications platform that integrates a comprehensive suite of clinically proven modalities including iFR, FFR, IVUS (intravascular ultrasound) and co-registration [7] to simplify complex interventions and speed routine procedures. With iFR pullback and co-registration, physicians can identify the precise locations causing ischemia, plan stent length and placement with a virtual stent, and predict physiologic improvement.

“With integration and co-registration on our IntraSight platform, measurement with iFR, and now enhanced wire performance thanks to OmniWire, we’re providing clinicians with an advanced solution at every step of the procedure,” said Chris Landon, Senior Vice President and General Manager Image Guided Therapy Devices, Philips. “Physicians can confidently use a functional guidance strategy across all their patients, including in complex and multi-vessel cases. Today’s announcement demonstrates how our unique portfolio of systems, smart devices, software and services combines to deliver advanced procedure-oriented solutions.”

OmniWire is now available in the U.S. and Japan and has received clearance from the U.S. Food and Drug Administration (FDA) and approval from the Japan Pharmaceuticals and Medical Devices Agency.

About Royal Philips

Royal Philips is a leading health technology company focused on improving people’s health and enabling better outcomes across the health continuum from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2019 sales of EUR 19.5 billion and employs approximately 81,000 employees with sales and services in more than 100 countries.

Burjeel Hospital launches the first Excelsius- GPS Robot from GLOBUS MEDICAL in MENA region for performing spine surgeries

Burjeel Hospital launches the first Excelsius- GPS Robot from GLOBUS MEDICAL in MENA region for performing spine surgeries

Burjeel Hospital in Abu Dhabi announced the launch of the first E-GPS Robot from Globus Medical in Middle East. The E-GPS Robot or Excelsius-GPS is used in spine surgeries for accurate screw placements. It is a break-through innovation in spine surgery, developed by, Globus Medical, USA.

Mr. John Sunil, CEO of Burjeel Hospital, said: “We constantly monitor the developments and innovations in the healthcare industry and embrace technologies that help us to serve our guests the better. We are pleased to be the first in the MENA region to launch the ‘Excelsius- GPS Robot’ technology at Burjeel Hospital. This would help our specialist doctors to perform complicated procedures with greater precision. We believe the adoption of the latest robotic technology will help us in delivering superior-quality treatment to our guests.”

The launch was held on 17th August 2020 at Burjeel Hospital with an initial training given to surgeons from the department of Neurosciences on the E-GPS System.

Prof. Amr El Shawarbi, Consultant Neurosurgeon and Medical Director of Neurosciences (VPS) at Burjeel Hospital, said: “The Excelsius-GPS Robot is one of the latest and finest technologies available in the world that helps surgeons do spine surgeries with greater precision and accuracy. The robotic-technique enabled machine reduces the time for the surgery and helps the doctors in delivering better outcomes. Artificial Intelligence and Robotic technologies have revolutionized health care. The adoption of this technology will enable the specialist doctors at Burjeel Hospital to improve the efficiency of the services being delivered.”

At present, the Excelsius-GPS robotic surgery program is available in more than 100 leading hospitals and institutions world-wide. Remarkably, Burjeel Hospital has pioneered to implement this program in MENA region for the first time. The robot is designed to optimize patient care, reduce operating time and improve accuracy by using both robotics and navigation.

“FourMed has been consistently providing innovative and quality healthcare solutions in the region. We are exhilarated as a channel partner in driving the launch of E-GPS robotic program at Burjeel Hospital. It is a delight to be associated with Globus Medical and Burjeel Hospital, and in continuing our efforts to deliver break-through healthcare technologies.”, said Samer Masri, Managing Director, FourMed.

“The launch of E-GPS Robot in Burjeel Hospital demonstrates our continued commitment to democratize robotics and advanced technologies in hospitals. The newly launched E-GPS robotic program in Burjeel Hospital under the expertise of Prof. Amr El Shawarbi will further strengthen the quality of treatment provided,” said Keswin Suresh, Product Manager, Robotics & Innovations, FourMed.

Atul Sood, Regional Lead, UAE, India & SEA, Imaging Navigation & Robotics, Globus Medical said “We are excited to have the E-GPS robotic program launched with Prof. Amr El Shawarby and Burjeel Hospital. The E-GPS robot will benefit the patient and surgeon equally in achieving better clinical outcomes.”

Health Catalyst and Northwell Health Partner to Transform Patient Care with Cloud-Based Data and Analytics Enterprise Solution

Health Catalyst and Northwell Health Partner to Transform Patient Care with Cloud-Based Data and Analytics Enterprise Solution

Northwell Health joined Health Catalyst, Inc., a leading provider of data and analytics technology and services to healthcare organizations, in announcing a long-term strategic partnership to transform the quality of patient care by using data and analytics to better anticipate and respond to the evolving needs of patients, providers and payers in today’s rapidly evolving healthcare ecosystem.

In this partnership, Health Catalyst will provide solutions to allow for increased cloud-based reliance on data and analytics, while sharing insights and best practices from a decade of support to hundreds of other healthcare clients. This will accelerate greater efficiency in data mapping and data storage to/with the Electronic Medical Record (EMR) and the affordable emergence of an enterprise solution for meaningful and measurable clinical, financial and operational improvements. The solutions will be used across the Northwell Health enterprise, which includes the Feinstein Institute and Donald and Barbara Zucker School of Medicine at Hofstra.

“Northwell Health’s goal is a simple one that has not changed since our inception: Be better tomorrow than we are today. Partnering with Health Catalyst will allow us to accelerate the generation of critical insights for one of the world’s most diverse patient populations which includes more than 11 million individuals who will potentially turn to us for care,” said Michael Dowling, President and CEO of Northwell Health. “Health Catalyst’s Augmented Intelligence (AI) and data science experience and expertise, along with our shared cultural attributes and mission alignment, will allow us to use data-informed decision making to achieve our shared commitment of transforming healthcare for the communities we serve.”

Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, nearly 800 outpatient facilities and more than 18,500 affiliated physicians. More than 11,000 COVID-19 patients have received care from Northwell’s 16,000-plus nurses and 4,000 employed doctors, including members of Northwell Health Physician Partners, and using 1,600 additional COVID-19 focused beds.

This partnership will be built using Health Catalyst’s DOS™ technology, a data-first analytics and application platform, to capture and map raw data into meaningful, actionable insights. Northwell Health will also immediately have access to Health Catalyst’s growing suite of COVID-19 solutions, including but not limited to a registry, staff and patient tracker and capacity planning tool. Broadly sharing Northwell Health’s data driven insights from its COVID-19 work is another significant opportunity for transformational care.

“Health Catalyst will become our data and analytics backbone, as their Solutions will enable our organization to take our current data adoption and transformation to entirely new heights,” said John Bosco, Senior Vice President and Chief Information Officer at Northwell Health. “We are looking forward to leaning on DOS to create an affordable, yet innovative enterprise solution that will further enable transformative care to the patients we serve.”

About Northwell Health
Northwell Health is New York State’s largest health care provider and private employer, with 23 hospitals, 665 outpatient facilities and more than 18,500 affiliated physicians. We care for over two million people annually in the New York metro area and beyond, thanks to philanthropic support from our communities. Our 66,000 employees – 16,000-plus nurses and 4,000 employed doctors, including members of Northwell Health Physician Partners – are working to change health care for the better. We are making breakthroughs in medicine at the Feinstein Institute for Medical Research. We are training the next generation of medical professionals at the visionary Donald and Barbara Zucker School of Medicine at Hofstra/Northwell and the Hofstra Northwell School of Graduate Nursing and Physician Assistant Studies.

About Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations, and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its customers leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.

Addenbrooke’s: First UK hospital to offer advanced patient positioning and surface guided technology for radiotherapy patients

Addenbrooke's: first UK hospital to offer advanced patient positioning and surface guided technology for radiotherapy patients

Addenbrooke’s has become the first hospital in the UK to install a new technology to enable delivery of precision radiosurgery and radiotherapy to patients with cancer and other conditions.

Addenbrooke’s has become the first hospital in the UK to install a new technology to enable delivery of precision radiosurgery and radiotherapy to patients with cancer and other conditions using an advanced form of Surface Guided RadioTherapy (SGRT) and x-ray monitoring.

The £500,000 system from the medical technology company, BrainLab, based in Munich, combines 4D thermal-surface camera technology with real-time x-ray tracking, resulting in submillimetre accuracy in treatment delivery.

The more precisely the radiotherapy treatment delivery is targeted, the greater the chance of success in avoiding any inadvertent damage to neighbouring soft tissue or vital organs sensitive to radiation, whilst the target receives the high dose radiotherapy treatment as planned.

The system comprises of an optical surface scanner with 300,000 surface points and a thermal camera which acquires a unique thermal heat signature of the patient. This is the first global application of thermal imaging in the field of radiotherapy, specifically focusing on patient accuracy and delivery of radiation. The camera is used in conjunction with x-rays for initial patient positioning and to monitor movement throughout the treatment. Automatic x-ray imaging is used to ensure accurate targeting of the radiation therapy.

Every set of x-rays acquired generates a new reference surface including updated thermal information, which in turn creates another dimension to consistently track the patient’s position. This minimises any delay between any movement of the patient’s body and the treatment unit’s response.

This additional accuracy enables advanced treatments to be delivered on a daily basis, including Stereotactic Radiosurgery and Stereotactic Ablative Radiation (SABR). SABR requires fewer doses than standard radiotherapy, cutting the number of hospital visits that potentially vulnerable cancer patients need to make from 20-30 to around 5.

The installation of the system coincides with the Government’s recent announcement that SABR will be available across the NHS by the end of this financial year, rather than 2022 as originally planned.

It means Addenbrooke’s will be able to offer SABR treatment to patients not only with non-small cell lung cancer but also those with lung, lymph nodes and non-spine bone oligometastatic disease.

A further future enhancement coming soon by BrainLab, will enable staff to track and treat tumours, or lesions, that move or change size and shape over and during a course of treatment.

June Dean, associate radiotherapy manager and head of technical operations for the radiotherapy centre at Addenbrooke’s said: “Our focus is on making sure patients have access to high quality treatment that meets their needs.

“This system uses surface guidance for patient positioning with high quality imaging that enables us to reduce the use of high dose x-rays and ultimately to treat patients with far greater precision. Eventually, it will also allow us to successfully treat a broader range of patients, including patients with breast cancer who struggle to achieve deep inspiration breath hold; a technique that enables us to avoid treating the heart.

“We are really lucky to have it. Radiotherapy is a highly targeted treatment and anything we can do to spare healthy tissue is ultimately going to benefit the patient.”

Tara Djanani, clinical marketing manager for BrainLab, said: “The ExacTrac Dynamic launch has begun a new era of radiotherapy with the hybrid technology of 3D surface tracking and thermal acquisition with the assurance of configurable x-ray monitoring. The combination of tracking the patient’s external surface and correlating this to the internal anatomy enables healthcare professionals to deliver accurate treatment. We are very excited for Addenbrooke’s Hospital to be the first adopters of this technology. The combination of BrainLab’s Elements Treatment Planning Software which is already being used in the department and now ExacTrac Dynamic would enable a smooth workflow for the team and high quality treatments, including SRS and SABR to patients in the region. ”

Johns Hopkins Technology Startup, ROSE, Selected for Brigham and Women’s Hospital Pilot COVID-19 Program

Johns Hopkins Technology Startup, ROSE, Selected for Brigham and Women's Hospital Pilot COVID-19 Program

Rose, a Baltimore-based technology startup that provides a HIPAA-compliant mental health monitoring platform based on clinical trials and research by Johns Hopkins University, announced it was selected to support healthcare professionals around COVID-19 and mental health at the Brigham and Women’s Hospital Emergency Department.

During the pilot program, emergency health care professionals at Brigham and Women’s Hospital will receive access to the Rose platform, which assesses resilience by monitoring well-being levels and detecting changes in real-time. Each day, the platform collects data from users in the form of questionnaires and free-response journal entries, which can be completed in as little as 30 seconds.

The Rose platform is powered by patented artificial intelligence (AI) and Natural Language Processing (NLP) technology, which enables it to identify key indicators and warning markers for the presence and/or advancement of mental health symptoms in a user’s responses to questions and prompts. Rose can detect early warning signs of numerous mental health conditions, including anxiety, depression, and trauma.

In addition to monitoring the user’s well-being, the platform also provides each user with a personalized feed of curated content from Rose’s library of more than 1,000 articles and videos, based on the user’s history, behavior and app inputs.

“With more than 5 million confirmed COVID-19 cases in the U.S., many hospitals are overloaded with patients with no end in sight. The toll this pandemic has taken on the mental and emotional health of front-line workers cannot be overlooked. They are experiencing an unprecedented number of patients, cases, deaths, and risks to their own health, all of which exacts a heavy toll on their mental state. We simply can’t ignore this emerging crisis that threatens the mental health and stability of our essential workers – they need support,” said Kavi Misri, founder and CEO of Rose.

Catalyst @ Health 2.0, which develops and implements programs for piloting and commercializing health care technology, facilitated the pilot program selection process, which was part of its Rapid Response Open Calls initiative to connect health care providers to the digital health community in response to the pandemic.

“Rather than fragmented tools and programs aiming to ‘treat burnout,’ we need to better identify and tackle systemwide factors that lead to burnout, while promoting a healthy workplace for our healthcare workers,” said Dr. John Shivdat, Rose advisor and chairman and medical director of HCA Coliseum Health System in Georgia. “Rose is tailor-made to address this challenge – proactively identifying individuals who are at greater risk of burnout and customizing interventions and content to their unique needs, while providing mental health professionals with the data and insights necessary to deliver personalized content more efficiently and effectively.”

Drs. Hanni Stoklosa and Desiree Azizoddin of Brigham and Women’s Hospital’s Department of Emergency Medicine led the request for a digital platform to support EM clinicians. “The committee on wellness in the Brigham’s Department of Emergency Medicine is acutely aware of and prepared to support the clinicians who loyally care for patients during this COVID-19 pandemic,” Dr. Stoklosa said. Drs. Stoklosa and Azizoddin also acknowledge iHub Partners Digital Health for providing support which helped move this idea to fruition.

Rose is a comprehensive technology solution that provides a HIPAA-compliant mental health monitoring platform based on clinical trials and research by Johns Hopkins University. With only 30 seconds of daily use, health care providers and their patients can use Rose to track mental health, monitor stress levels, identify triggers and get ahead of more extreme events. Rose offers a mobile app for the 43 million Americans experiencing mental illnesses and an artificial intelligence-powered tool for health care providers to monitor and support their patients.

Tenacore Enters Distribution Agreement with IMT Analytics

Tenacore Enters Distribution Agreement with IMT Analytics

Tenacore LLC is pleased to announce the company has entered a distribution agreement with IMT Analytics AG, of Switzerland. Under the agreement, Tenacore LLC will sell the full line of IMT’s gas flow analyzers and ventilation test lungs.

IMT Analytics designs and manufactures gas flow analyzers that precisely measure flow, pressure, gas temperature, humidity, and oxygen concentration. They can be used to test many types of ventilators and a variety of medical gas flow and pressure devices such as oxygen concentrators, endoscopic insufflators, and anesthesia machines. The flow analyzers from IMT Analytics also perform calibration or verification during preventive or periodic maintenance or repair service.

“We are very pleased to be expanding our new product portfolio to include the highest quality biomedical test equipment designed and manufactured by IMT Analytics,” said Jim Willett, CEO of Tenacore LLC. “The flow analyzers are a logical addition to the Tenacore LLC products and services offering that will increase our ability to best serve our biomedical engineering customers.”

Tenacore LLC will distribute the IMT Analytics flow analyzers, as well as utilize the devices for repairs performed at company depot service facilities. The IMT Analytics products will be the first of multiple new biomedical testing devices that Tenacore LLC plans to distribute as the company expands its focus within the healthcare technology service and repair market.

“It is a great pleasure to add Tenacore LLC as a distributer for the flow analyzer product line,” said Harri Friberg, CEO of IMT Analytics. “We are recognizing ever increasing global demand for technologically advanced and easy to use flow analyzers and Tenacore LLC will help to ensure greater access throughout the biomedical engineering community through their existing and new customer relationships.”

IMT Analytics AG

IMT Analytics is a global leading manufacturer of certified measurement equipment and test lungs for respiratory and anesthetic devices. With headquarters in Buchs, Switzerland and a branch establishment in Singapore, the privately-owned company was founded in 2018 and emerged from imtmedical AG, which has specialized in high-performance medical ventilation and measuring devices since its founding in 1999.

About Tenacore

Tenacore LLC is a healthcare technology management company providing clinical equipment lifecycle solutions to the global healthcare technology community through quality service delivery and dedication to continuous improvement. Specializing in the depot-based service and repair of a broad range of medical equipment, Tenacore’s expansion across the United States paired with its multi-vendor service expertise and scalability uniquely positions the company to offer a cost effective and quality alternative to site-based service. In February of 2020, The Courtney Group based in Newport, CA, collaborated with Indianapolis based Centerfield Capital Partners to invest in the acquisition of Tenacore LLC.

Home Healthcare also Helping People in Post COVID-19 Recovery

Home Healthcare also Helping People in Post COVID-19 Recovery

Usually, recovery from any ailment is a painful journey, and getting back to normalcy is even more difficult as it affects an individual both physically and mentally. And in abnormal situations like COVID-19 and the immense impact, it has on patients’ lives, the road to recovery is naturally expected to be more intense. Physicians and Scientists are trying to understand the intricacies COVID-19, but the emergence of a new chapter about dealing with its after-effects on patients post-recovery have given them another food for thought.

As far as the recovery of COVID-19 patients is concerned, it’s important to remember that it’s not just patients with severe symptoms who have a long recovery ahead, but studies have shown that even those with mild symptoms can expect their lungs, heart and brain to be damaged. Other problems such as Post-Traumatic Stress Disorder, Fatigue, Joint pains, Swallowing, and Taste issues all take time to recover post-COVID Treatment/Isolation.

“The recovery time estimated by WHO is just the time an infected person takes to recover from the symptoms of COVID-19 in the hospital. However, the actual recovery may take a much longer time. People with mild disease may get better with time and may not face any long-term health issues. But, the recovery time for people who faced serious complications of COVID-19, such as respiratory distress or delirium, is higher. The post-recovery period is very crucial wherein apart from physical care, the mental health of the patients with the help of psychological counselling is essentially required. Considering the essence along with our Home Isolation Programme (HIP), we have come up with a special package for post-COVID-19 care” said Mr Vivek Srivastava, Co-Founder & CEO, HealthCare atHome (HCAH).

People who have recovered from COVID-19 infection officially, are not in complete wellness. As per the reports, they are still in sufferings such as lack of energy, breathlessness and loss of appetite. Due to the damage caused by the virus to the lungs and other organs, the body takes time to recover and get back to its former state. Till that time, the person may have to pay attention to their immunity levels and more importantly proper care at home is required, which can be performed by the experts of home isolation care.

Elaborating on the essence of post-COVID-19 recovery care, Dr Gaurav Thukral, COO, HealthCare atHOME (HCAH), said, “Considering the post-COVID-19 recovery complications, we have launched post COVID care packages, which will ensure a complete recovery from the disease, help build respiratory strength, and restore physical and mental immunity of the patients. The cost-effective care and follow up support in the comfort and safety of the patient’s home by the help of 360-degree care by trained and experienced medical staff is one of the salient features of the package.”

“The package focuses on mental health with the help of psychological counselling & support. For this, Doctor’s consultations and specialized care with supervised physiotherapy sessions and app-based exercise program will be provided. With the help of an antibody titer test, immunity booster diet plan and immunity markers will be provided. The 24X7 helpline will also be available”, added Dr Thukral.

Sharing his experience of the patients who are suffering post-COVID-19 recovery, Dr Arup Basu, Senior Chest Physician at Sir Ganga Ram Hospital, Delhi, said, “COVID-19 is known to damage the lungs. Even after the infection subsides, scars caused by it remains. The scars or thickened tissues make it difficult for the lungs to work properly. That’s the reason why oxygen support is needed to keep the patient alive.”

He added further, “I have come across a 22-year-old patient who recovered from COVID-19 a month ago but is still in ICU and requiring high flow oxygen support. Also a 64-year-old businessman from Karol Bagh, Delhi was diagnosed with COVID-19 in May first week and has been still requiring oxygen support to be able to breathe, and it is also difficult for him to go to the bathroom.”

The COVID-19 game is not over. We are between COVID-19. We should not lower our guard. We still need to continue the same precautions that we have been taking over the last five odd months. The virus is still looming very large nearby us. And the post COVID recovery care is as important as the treatment of new cases of COVID-19.

Lumenis announces its latest aesthetic medical device: NuEra tight with FocalRF Technology

Lumenis announces its latest aesthetic medical device: NuEra tight with FocalRF Technology

Lumenis Ltd., the world’s largest energy-based medical device company for aesthetic, surgical and ophthalmic applications, is proud to announce its latest innovation, the NuEra Tight with FocalRF technology. The platform introduces a breakthrough in personalized non-invasive RF body treatments to match the unique needs of every patient.

NuEra Tight with FocalRF technology was developed to provide tailored body treatments to a patient’s distinctive needs. The new technology gives practitioners advanced tools for today’s aesthetic patients, accounting for clinical indications and specific body areas, all in one device.

“Radio Frequency treatments are among the most requested aesthetic therapies today,” said Macrene Alexiades-Armenakas, MD, PhD, FAAD, Clinical Dermatologist, Laser Surgeon and Researcher Dermatologist, New York. “NuEra Tight with FocalRF technology is highly customizable with a wide selection of frequencies and handpieces that deliver fast, comfortable and non-invasive treatments. This results in my patients’ achieving their desired improved appearance, while ensuring safety and efficacy. This device is painless yet effective in body contouring, a game-changer for my patients.”

The system’s easy to use interface features NuAPIC™ (Automatic Personalized Intelligent Control) which ensures the therapeutic temperature throughout the procedure, as well as the innovative NuLogic™ advanced protocol customization tool, that enhances further personalization for optimal treatment.

“One size doesn’t fit all. That’s why we revolutionized the NuEra Tight,” said Tzipi Ozer-Armon, CEO of Lumenis. “We recognized the need for the next level solution in non-invasive body treatments, which led us to create a device that tailors a treatment specifically for a particular condition and body area. We developed FocalRF to accurately target various skin conditions throughout the procedure, resulting in a treatment that is as unique as your patients.”

NuEra Tight will be available worldwide starting with the United States in August 2020 and Europe, the Middle East and Asia later this year. Please visit lumenis.com for more information about the Lumenis family of products.

About Lumenis
Lumenis is a global leader in the field of minimally-invasive clinical solutions for the Surgical, Ophthalmology, and Aesthetic markets, and is a world-renowned expert in developing and commercializing innovative energy-based technologies, including Laser, Intense Pulsed Light (IPL) and Radio-Frequency (RF). For over 50 years, Lumenis’ ground-breaking products have redefined medical treatments and have set numerous technological and clinical gold-standards. Lumenis has successfully created solutions for previously untreatable conditions, as well as designed advanced technologies that have revolutionized existing treatment methods. Lumenis is a portfolio company of Baring Private Equity Asia.

MediConnect and Rishabh Software to build medical supply chain management platform

UK-based medtech company MediConnect have announced a new partnership with software specialists Rishabh Software to build a pilot version of their new medical supply chain management platform. The platform will be the first blockchain-based application to manage the supply chain for ordering personal protective equipment (PPE) and medication across multiple health care practices.

WHY IT MATTERS

MediConnect, who have already developed a framework blockchain solution to help organise the medical supply chain, have taken on Rishabh Software as their technical development partners. Rishabh Software will work closely with blockchain developers Stratis to design and develop the platform.

Since the software will allow the trace of the source of manufactured goods, it is hoped that the application will prevent the distribution of counterfeit PPE and other pharmaceutical products, while also ensuring that demand is met by streamlining different types of workflow events and documentation.

The platform will also enable interactions between several parties, including manufacturers, wholesalers, key workers, patients and retailers, to securely share transaction records. These will then be verified using MEDI tokens, which will enable the transaction.

The application will be web-based, available via both desktop and mobile, and will utilise Stratis blockchain to execute smart contracts.

The pilot is designed to show how supply chain transactions can be placed and carried out on a Test Platform established by MediConnect’s partners. The platform will be integrated to handle multiple distribution channels to online pharmacies and other partners who are registered on it.

THE LARGER TREND

MediConnect’s announcement comes at a time where supply chain management has become an ever increasing priority for hospitals and healthcare providers. In a 2019 survey conducted by supply chain management vendor Syft, as many as 27% of hospitals surveyed reported that they did not use analytics software to assess supply chains for areas where they might improve quality and efficiency.

Blockchain has also been seen increasingly as a means of protecting supply chains, for example in the pharmaceutical industry, and as a way to improve efficiency and go paperless.

ON THE RECORD

CEO of MediConnect, Dexter Blackstock, commented: “Having established a network of industry and NHS partners, we are thrilled to now be building our pioneering platform to manage and authenticate medical products. Rishabh Software are global specialists in software development. We look forward to a fruitful relationship and working together to launch a live platform as soon as possible.”

Rajendra Shah, CEO of Rishabh Software, confirmed the need for such a pilot in the health sector: ‘As a technology development partner, with two decades of service excellence, we are delighted to support MediConnect’s mission to supply and provide end-to-end tracking of PPE and other pharmaceutical and medical products throughout the world. In these uncertain and stressful times, MediConnect’s platform gives everybody the peace of mind that their healthcare products are authentic and safe to use.”

1...574575576...1,125Page 575 of 1,125

About us

Hospital & healthcare Management is a leading B2B arena designed for the healthcare sector, it allow members to reach both ends of the healthcare facility procurement chain. . . Read More

Subscribe us

System

Resources

Archive Links

Subscribe

Copyright © 2008 - 2026 Hospital & Healthcare Management. All rights reserved. Publication of Leo Marcom Pvt Ltd.

Translate »